April 2026 in “Journal of Pharmaceutical Investigation” This review discusses the potential of nanotechnology in treating hypertrophic scarring and atopic dermatitis (AD) by reprogramming the pathological skin microenvironment. Both conditions involve excessive fibrosis, chronic inflammation, immune dysregulation, and oxidative stress. Nanotherapeutic strategies, such as TGF-β siRNA delivery, ROS scavenging nanozymes, and lipid-replenishing nanoparticles, are highlighted for their ability to enhance skin penetration and retention, offering anti-fibrotic, anti-inflammatory, immunomodulatory, and barrier-restorative effects. The review suggests that future cutaneous nanotherapy will integrate regenerative and immunological strategies, moving towards personalized nanomedicine and bioinspired materials. However, ensuring long-term safety and targeting efficiency is crucial for clinical adoption.
February 2026 in “Biomaterials” BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.
November 2025 in “Trends in Immunotherapy” Exosomes from certain cells can improve hair regrowth by changing the immune response.
February 2026 in “Exploration” Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.
August 2023 in “Molecules and Cells” Hair can regrow after significant damage through a process similar to how it forms before birth, involving stem cells and various cell types and signals. This could be a new way to prevent scarring and promote hair growth.